Pesticide- alphabetically listed

Consultation Documents: Proposed Registration Decision (PRD), Proposed Maximum Residue Limits (PMRL),
Proposed Special Review Decision (PSRD)

SFM Comments on the specific Consultation Document


Acynonapyr and Kodama Miticide 

PRD 2026-03 Acynonapyr Comments

Abamectin 

2024 09 13 MRL Consultation: Filing on PMRL 2024-13: SFM Abamectin SubmissionvFinal

– supporting documents: Syngenta Evaluation Report 24484 PMRA No 2566198 ; Abamectin_Integrated_Assessment_3230165

SFM_PRD2026-05_Abamectin_Comments_202606
See also: Capture of Health Canada by Syngenta – Abamectin

Azoxystrobin

PMRL 02-38 comments

PMRL 2023 34 and 38 SFM Additional Comments

Chlorantranliprole

PMRL 2025-11 Chlorantraniliprole – SFM Comments 2 20251110

CPTH (3-chloro-4-methylaniline hydrochloride)

SFM Comments_PMRL2025-15_Metamitronv2

Cyantranililprole

PMRL 2025-09 Cyantraniliprole – SFM Comments v2 20251110

Cyclobutrifluram – SFM has also sued (see Court filings)

PRD2025-06 Cyclobutrifluram

PRD 2025-06 SFM Comments

PMRL 2025-19 Cyclobutrifluram

Cyclobutrifluram_Comprehensive Comments finalv1

Cyclobutrifluram Re-evaluation Decision 2025-12-19

Notice of Application: T-221-26 SFM et al v AG Minister of Health

Deltamethrin

PRD2026-12-deltamethrin – eng

SFM_Comments_PRD2026-12_Deltamethrin 20260808

Dimethenamid

PMRL 2025-13 Dimethenamid SFM Commentsv1

Epyrifenacil

PRD2026-13 Epyrifenacil

SFM_PRD2026-13_PMRL2026-08_Epyrifenacil_Comments 20260920v1

Fenazaquin

PMRL 2025-10 Fenazaquin – SFM Comments

PMRL 2025-10 Fenazaquin – SFM Commentsv2 20251110

Fludioxonil

PMRL 2023-34 Comments

PMRL 2023 34 and 38 SFM Additional Comments

Fluoxapiproline

PRD2025-07-Fluoxapiproline and Xivana Prime

PRD 2025-07 SFM Comments

pmrl2025-20-en

Fluoxapiprolin_Comprehensive_Comments_PMRL2025-20

Flutianil 

SFM_PRD2026-08_Flutianil_v20260614

Isocycloseram –  SFM has also sued on both 2025 and 2026 decisions (see Court filings)

PRD H113-9-2025-11-eng

PRD 2025-11 SFM Commentsv2

PMRL 2025-21 Isocycloseram

PMRL2025-21_SFM_Comments

RD2026-03-Isocyloseram

PRD 2026-02 Isocycloseram

PMRL 2026-03 Isocycloseram

PMRL 2026-03 SFM Comments

Famoxadone

2026 06 29 SFM Comments PRVD2026-02 Famoxadone (1)

Famoxadone PRVD2026-02 eng

Fluoxapiprolin

PRD 2025-07 Fluoxapiprolin SFM Comments

Flutianil

SFM_PRD2026-08_Flutianil_v20260614

Inpyrfluxam

SFM Comments PMRL 2025-16 Inpyrfluxam (1)

MCPA

PSRD2026-01-eng

SFM Comments PSRD2026-01 MCPA 20260716

Mefentrifluconazole

SFM Comments on PMRL 2023-41 Mefentrifluconazole

Metamitron

SFM Comments_PMRL2025-15_Metamitronv2R (1)

Picarbutrazox

SFM Comments on PMRL 2025-17 Picarbutrazox (1)

Pyriofenone

PRD 2025-06 SFM Comments

PMRL 2025-12 Pyriofenone SFM Commentsv2

PMRL 2025-12 Pyriofenone SFM Commentsv1

Sedaxane

SFM_PMRL2026-01_Sedaxane_Comments_v22060405 (1)

Spiropidion

PRD2026-09-eng Proposed Registration Decision 

PRD2026-09_SFM_Comments 20260720vFinal

RD2026-16-Eng Directorate’s Responses & Decision 20260812

Notice of Objection –  SFM submission Oct 11 2026

Tebuconazole

2025 01 14 – Tebuconazole Notice of Objection to RD

2026 08 10 Directorate Tebuconazole NoO Decision Letter_to Ecojustice_

Tiafenacil

Notice of Objection (NoO)

2023 03 Additions to Tiafenacil NoOvfinal (1)

Triallate

SFM comments PMRL 2025-18 Triallate (1)

Trinexapacethyl

PMRL 2025-14 Trinexapacethyl SFM Comments